LIR Life Sciences Corp. (CSE:SKNY)
Canada
· Delayed Price · Currency is CAD 1.370
+0.180 (15.13%)
At close: Dec 5, 2025
LIR Life Sciences Statistics
Total Valuation
CSE:SKNY has a market cap or net worth of CAD 25.96 million. The enterprise value is 25.99 million.
| Market Cap | 25.96M |
| Enterprise Value | 25.99M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:SKNY has 18.95 million shares outstanding.
| Current Share Class | 18.95M |
| Shares Outstanding | 18.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.77% |
| Owned by Institutions (%) | n/a |
| Float | 17.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -89.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -63.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,903.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 141.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.04 |
| Average Volume (20 Days) | 101,307 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -10,000 |
| Operating Income | -412,354 |
| Pretax Income | -412,496 |
| Net Income | -412,496 |
| EBITDA | n/a |
| EBIT | -412,354 |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 2,612 in cash and 35,000 in debt, giving a net cash position of -32,388 or -0.00 per share.
| Cash & Cash Equivalents | 2,612 |
| Total Debt | 35,000 |
| Net Cash | -32,388 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -291,568 |
| Book Value Per Share | -0.02 |
| Working Capital | -395,532 |
Cash Flow
| Operating Cash Flow | -212,643 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:SKNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.59% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 7, 2025. It was a reverse split with a ratio of 0.6666667.
| Last Split Date | Nov 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.6666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |